Abstract

Conducted numerous experimental studies prove that the dipeptide (Lys-Glu) significantly enhances the proliferative activity of T-lymphocytes, accelerating their differentiation and migration rate, as well as the proliferative potential of stem cells of the stomach and intestines. In our opinion, this particular biological activity of the dipeptide contributes to the stimulation of the restoration of the structural and functional organization of the gastric mucosa, which leads to an improvement in the clinical picture. In this regard, the biologically active food supplement Vilon can be recommended as a maintenance immunomodulatory therapy in patients with chronic atrophic gastritis.

Keywords: Helicobacter pylori (HP); Dipeptide; Chronic Atrophic Gastritis

References

1. Anisimov VN and Khavinson VKh. “Peptide bioregulation of aging: results and prospects”. Biogerontology2 (2010): 139-149.
2. Avolio F., et al. “Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line”. International Journal of Molecular Sciences 7 (2022): 3607.
3. Caputi S., et al. “Effect of short peptides on neuronal differentiation of stem cells”. International Journal of Immunopathology and Pharmacology 33 (2019): 2058738419828613.
4. Fedoreeva LI., et al. “Short exogenous peptides regulate expression of CLE, KNOX1 and GRF family genes”. Biochemistry 82.4 (2017): 700-
5. Fedoreeva LI., et al. “Penetration of short fluorescence-labeled peptides into nucleus in HeLa cells and specific interaction of peptides with deoxyribo-oligonucleotides and DNA in vitro”. Biochemistry 11 (2011): 1505-1516.
6. Ilina A., et al. “Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease”. International Journal of Molecular Sciences8 (2022): 4259.
7. Khavinson VKh. “Peptides, Genome, Aging”. Advances in Gerontology4 (2014): 337-345.
8. Khavinson VKh., et al. “Effect of vilon on indicators of biological age and life expectancy of mice”. Bulletin of Experimental Biology and Medicine7 (2000): 88-91.
9. Khavinson VKh and Malinin VV. “Gerontological aspects of genome peptide regulation”. Basel (Switzerland): Karger A.G (2005): 104.
10. Khavinson VKh., et al. “Effect of Lys/Glu peptide on interleukin/2 gene expression in lymphocytes”. Bulletin of Experimental Biology and Medicine 9 (2000): 330-332.
11. Khavinson VKh., et al. “Short peptides penetrating into cell: model of interaction with gene promoter sites”. Bulletin of Experimental Biology and Medicine 3 (2012): 403-410.
12. Lahner E., et al. “Treatment of Helicobacter pylori infection in atrophic gastritis”. World Journal of Gastroenterology 22 (2018): 2373-2380.
13. Oliver A., et al. “The role of gastric microbiota in gastric cancer”. Gut Microbes5 (2020): 1220-1230.
14. Reihlin NT., et al. “Expression of argyrophilic proteins of nucleus organizer regions in human thymocytes and epithelial cells of thymus under co-culture conditions under action of peptides vilon and epitalon”. Bulletin of Experimental Biology and Medicine 6 (2004): 667-670.
15. Rembiasz K., et al. “Multifocal atrophic gastritis: pathogenesis and therapeutic implications”. European Journal of Gastroenterology and Hepatology 8 (2005): 857-863.
16. Sugano K., et al. “Kyoto global consensus report on Helicobacter pylori gastritis”. Gut 9 (2015): 1353-1367.
17. Trofimov AV., et al. “Neuroendocrine cells of gastrointestinal tract in models of premature aging”. SPb: Dean Publisher (2005): 208.
18. Trofimova SV., et al. “Medicinal Peptide Drugs: A Promising Direction in Modern Pharmacology”. EC Clinical and Medical Case Reports3 (2022): 17-24.
19. Vanyushin BF and Khavinson VKh. “Short biologically active peptides as epigenetic modulators of gene activity. II Epigenetics - a different way of looking at genetics”. Springer International Publishing Switzerland. Walter Doerfler and Petra Biihm (eds.) (2016): 69-90.
20. Wang J., et al. “Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis”. 83.4 (2011): 253-260.